Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-22-021491
Filing Date
2022-06-01
Accepted
2022-06-01 17:00:32
Documents
2
Period of Report
2022-05-31

Document Format Files

Seq Description Document Type Size
1 FORM 3 form3.html 3  
1 FORM 3 form3.xml 3 1480
2 EXHIBIT 24.1 brhc10038381_ex24-1.htm EX-24.1 9043
  Complete submission text file 0001140361-22-021491.txt   12191
Mailing Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220
Business Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220 (212) 582-1199
Brooklyn ImmunoTherapeutics, Inc. (Issuer) CIK: 0000748592 (see all company filings)

EIN.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 11988 EL CAMINO REAL STE. 650 SAN DIEGO CA 92130
Business Address
Jackson Andrew C. (Reporting) CIK: 0001636738 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-11460 | Film No.: 22988135